A Real-World Study on Extranodal Lymphoma

Not yet recruiting

• Conditions: Lymphoma; Lymphoma, B-Cell; Extranodal Lymphoma; Lymphoma, Non-Hodgkin; Diffuse Large B Cell Lymphoma

• Registration Number: NCT06573099
• Lead Sponsor: Ruijin Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-8-8
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Not yet recruiting
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

Inclusion Criteria:<br><br> 1. Age = 18 years (including 18 years old).<br><br> 2. Patients newly diagnosed with non-Hodgkin lymphoma with extranodal involvement,<br> whether it is primary, secondary, or cannot be determined.<br><br> 3. Patients who have received systematic clinical treatment.<br><br> 4. Patients with measurable lesions, at least containing one effective evaluation of<br> efficacy.<br><br>Exclusion Criteria:<br><br> 1. Patients who only receive supportive treatment.<br><br> 2. Patients who cannot obtain effective evaluation data of efficacy.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Progression Free Survival (PFS)

Secondary Outcome Measures

Name	Time	Method
Overall Survival (OS)